Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $114.47 | $24.85 | 360.69% | 215.98x | 196.21x | 14.52x | 17.53x | 1.67x | $106.92M | 0.89% | $705.78M | 6.70 | $12.27B | 1,564.36 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $228.65 | $95.79 | 138.69% | 37.48x | 31.56x | 6.36x | 22.59x | 1.14x | $793.95M | 2.60% | $1.35B | 10.14 | $31.87B | 27.03 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.19 | $8.41 | 211.45% | 124.71x | 162.77x | 7.37x | 14.92x | 1.15x | $39.15M | 1.15% | $220.58M | 1.69 | $3.37B | 74.27 | ||
| VCEL | VERICEL CORP | $44.20 | $9.00 | 391.04% | 92.08x | 91.68x | 7.37x | 6.12x | 2.18x | $61.66M | 2.73% | $370.04M | 7.25 | $2.23B | 50.64 | ||
| RPRX | ROYALTY PHARMA PLC | $58.60 | $38.99 | 50.28% | 31.17x | 10.92x | 10.28x | 3.44x | 0.64x | $2.92B | 11.21% | $9.79B | 21.99 | $41.84B | 35.58 | ||
| HALO | HALOZYME THERAPEUTICS INC | $98.66 | $71.77 | 37.47% | 27.71x | 11.89x | 6.95x | 78.01x | 0.59x | $806.22M | 6.97% | $143.54M | 1.22 | $13.18B | 18.35 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.75 | $16.63 | 361.53% | 71.73x | 60.96x | 7.08x | 9.15x | 2.22x | $182.84M | 3.07% | $654.15M | 8.43 | $5.82B | 48.53 | ||
| KRYS | KRYSTAL BIOTECH INC | $332.27 | $87.44 | 279.99% | 40.18x | 43.57x | 22.27x | 7.24x | 2.37x | $257.78M | 2.63% | $1.36B | 46.03 | $9.42B | 40.36 | ||
| ADMA | ADMA BIOLOGICS INC | $9.47 | $8.84 | 7.07% | 13.15x | 11.29x | 4.22x | 5.20x | 0.59x | $116.47M | 5.39% | $408.21M | 1.79 | $2.18B | 9.37 | ||
| TGTX | TG THERAPEUTICS INC | $48.74 | $24.15 | 101.81% | 15.82x | 34.59x | 8.64x | 12.35x | 1.85x | $17.39M | 0.25% | $604.08M | 4.26 | $7.73B | 55.52 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.32 | $9.56 | 18.40% | 11.92x | 10.93x | 4.92x | 3.09x | 0.77x | $82.01M | 12.24% | $217.65M | 3.68 | $528.40M | 6.83 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $67.36 | $21.50 | 213.30% | 177.26x | 18.13x | 3.82x | 2.06x | 1.11x | $738.18M | 5.67% | $6.32B | 32.68 | $16.35B | 42.39 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.02 | $2.27 | 33.31% | 15.10x | 13.06x | 1.86x | 2.90x | 0.78x | $5.67M | 2.38% | $82.53M | 1.04 | $174.55M | 9.34 | ||
| EXEL | EXELIXIS INC | $51.24 | $28.76 | 78.16% | 15.57x | 15.92x | 5.28x | 6.89x | 1.38x | $1.17B | 9.12% | $1.84B | 7.35 | $12.58B | 11.57 | ||
| MDXG | MIMEDX GROUP INC | $4.27 | $1.12 | 281.05% | 106.75x | -38.06x | 1.78x | 2.88x | 1.51x | $44.50M | 7.05% | $216.00M | 1.46 | $503.76M | 22.09 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $244.96 | $197.24 | 24.19% | 16.05x | 9.49x | 3.36x | 3.31x | 0.66x | $1.62B | 10.46% | $4.80B | 75.98 | $18.68B | 11.55 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.23 | $6.52 | -81.13% | 8.79x | -4.16x | 1.52x | 1.62x | 0.07x | $19.58M | 27.48% | $44.20M | 0.76 | $22.90M | 3.00 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $294.60 | $94.56 | 211.54% | 29.25x | 31.88x | 20.34x | 6.07x | 2.20x | $130.62M | 2.21% | $967.52M | 48.22 | $6.00B | 21.50 | ||
| TECH | BIO-TECHNE CORP | $72.40 | $16.14 | 348.60% | 101.97x | 34.70x | 9.35x | 5.44x | 1.87x | $269.60M | 2.38% | $2.09B | 13.34 | $11.42B | 44.60 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $803.48 | $419.75 | 91.42% | 19.16x | 17.21x | 5.32x | 2.61x | 1.26x | $3.76B | 4.55% | $31.71B | 308.48 | $82.97B | 14.43 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.12 | $33.18 | 14.89% | 12.14x | 10.04x | 2.30x | 2.22x | 0.72x | $354.90M | 16.07% | $999.24M | 17.25 | $1.82B | 6.51 | ||
| UTHR | UNITED THERAPEUTICS CORP | $499.73 | $226.17 | 120.95% | 16.53x | 18.26x | 6.75x | 19.13x | 2.23x | $1.09B | 5.13% | $6.40B | 150.24 | $120.63B | 71.95 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $505.75 | $158.95 | 218.19% | 29.18x | 26.15x | 10.19x | 6.33x | 2.31x | $3.80B | 2.96% | $20.25B | 79.81 | $124.02B | 22.54 | ||
| INCY | INCYTE CORP | $120.16 | $60.88 | 97.38% | 14.80x | 15.81x | 4.14x | 3.84x | 1.98x | $1.92B | 7.98% | $6.34B | 31.66 | $20.40B | 9.87 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.